Keith C. Meyer

Center for Infectious Disease Research — United States

Medicine · Health Sciences

58h-index13.2kcitations266works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Transplantation: Methods and Outcomes(104), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(93), Organ Transplantation Techniques and Outcomes(41), Medical Imaging and Pathology Studies(27), Sarcoidosis and Beryllium Toxicity Research(22)

Publications262 total

Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets
PLoS Pathogens·2025Open Access
Liver biopsies obtained throughout SIV infection reveal evolving interferon stimulated protein expression within distinct monocyte/macrophage subsets
2025Open Access
The Role of Serum Albumin and Secretory Phospholipase A2 in Sepsis
International Journal of Molecular Sciences·2024· 5 citedOpen Access
The Saga of Recombinant Human Pentraxin-2 as a Potential Therapeutic Agent for Pulmonary Fibrosis
Touch reviews in respiratory & pulmonary diseases.·2024· 2 citedOpen Access
Human Serum Albumin Misfolding in Aging and Disease
International Journal of Molecular Sciences·2022· 12 citedOpen Access
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension study
Respiratory Research·2022· 28 citedOpen Access
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease
European Respiratory Review·2021· 52 citedOpen Access
ISHLT consensus document on lung transplantation in patients with connective tissue disease: Part I: Epidemiology, assessment of extrapulmonary conditions, candidate evaluation, selection criteria, and pathology statements
The Journal of Heart and Lung Transplantation·2021· 37 cited
Optimizing virus protection in lung transplant recipients: Don’t drop the ball
American Journal of Transplantation·2021Open Access
Acute exacerbations of interstitial lung disease: what is the best treatment?
PubMed·2021· 2 citedOpen Access
Risks of lung transplantation in the SARS-CoV-2 era
The Lancet Respiratory Medicine·2020· 3 citedOpen Access
Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients
UNC Libraries·2020Open Access
Aging-Related and Gender Specific Albumin Misfolding in Alzheimer’s Disease
Journal of Alzheimer s Disease Reports·2020· 8 citedOpen Access
Treatment of primary sjögren's syndrome-related interstitial lung disease: a retrospective cohort study.
PubMed·2020· 15 citedOpen Access
Therapeutic Approach to Chronic Venous Insufficiency - Clinical Benefits of Red-Vine-Leaf-Extract AS 195 (Antistax)
Journal of Vascular Surgery Venous and Lymphatic Disorders·2019· 5 citedOpen Access
Pulmonary hypertension associated with idiopathic interstitial pneumonia: is effective pharmacotherapy an impossible dream?
The Lancet Respiratory Medicine·2019· 1 cited
Direct human health risks of increased atmospheric carbon dioxide
Nature Sustainability·2019· 561 cited
High Lung Allocation Scores and Lung Transplantation
CHEST Journal·2019· 2 citedOpen Access
P3‐078: AGING‐RELATED PROTEIN MISFOLDING AND NEURODEGENERATIVE DISEASES
Alzheimer s & Dementia·2019Open Access
Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study
The Lancet Respiratory Medicine·2019· 99 cited
page 1 of 14Next →

Frequent Co-authors

Ganesh Raghu(9), Dieter Worlitzsch(5), Gerd Döring(5), Martina Ulrich(4), Robert B. Love(4), Nancy S. Rosenthal(4), Robert Tarran(3), Ute Schwab(3), Aynur Cekici(3), P. Birrer(3), G. Bellon(3), Jürgen Berger(3), Tilo Weiß(3), K Botzenhart(3), James R. Yankaskas(3), Scott H. Randell(3), Richard C. Boucher(3), R. Braun(3), Mary S. Hayney(3), José Torrealba(3)